# Effect of Magnesium Sulphate Added to Mepivacaine Hydrochloride on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial.

> **NCT04561921** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 56 (estimated)

## Conditions studied

- Success of Inferior Alveolar Nerve Block

## Interventions

- **DRUG:** Magnesium sulfate
- **DRUG:** Mepivacaine-Levonordefrin Hydrochloride

## Key facts

- **NCT ID:** NCT04561921
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-22
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2020-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04561921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04561921, "Effect of Magnesium Sulphate Added to Mepivacaine Hydrochloride on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial.". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04561921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*